MedPath

A clinical study by using Agnimukh Churna with Kapitthashtak Churna in Irritable Bowel Syndrome Disease.

Phase 4
Conditions
Health Condition 1: K318- Other specified diseases of stomach and duodenum
Registration Number
CTRI/2023/04/051671
Lead Sponsor
Dr Ankita PAtil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients between 16-60 years of all genders.

2.Patients having lakshanas of grahani.

For Eg. Aruchi, Kshudhamadhya, Bahudravasaranam, Murhubaddham Murhudravam, Udardaha

Exclusion Criteria

Patients with major other diseases and who dont give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate efficacy of Agnimukha churna on symptoms of Grahani as per subjective and objective assesment mentioned in the synopsisTimepoint: The improvement in the symptoms of Grahani with the help of Izumo scale will be graded at each follow up of 7th, 14th, 21st and 28th day.
Secondary Outcome Measures
NameTimeMethod
To compare mode of action of agnimukha churna and kapitthastak churna in the management of grahani. <br/ ><br>To check the safety or Adverse effects of the drugs.Timepoint: At every follow up i.e.on 7th,14th,21st and 28th day the comparative study will be done and safety will be assesed.
© Copyright 2025. All Rights Reserved by MedPath